Skip to content

Organon OGN Deferred Tax Assets

Deferred Tax Assets at other companies

Pfizer logo
PfizerPFE
-$12M-101%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$96.4M-2.7%
Biogen logo
BiogenBIIB
$483.5M+263%
AbbVie logo
AbbVieABBV
$137M-94.7%
PBH
Prestige Consumer HealthcarePBH
$447.42M+6.6%
Viatris logo
ViatrisVTRS
$1.11B+35.7%

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's deferred tax assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's deferred tax assets?
Organon (OGN) reported deferred tax assets of $56M in Q1 2026.
How has Organon's deferred tax assets changed year-over-year?
Organon's deferred tax assets decreased by 18.8% year-over-year, from $69M to $56M.
What is the long-term trend for Organon's deferred tax assets?
Over 4 years (2021 to 2025), Organon's deferred tax assets has grown at a -0.2% compound annual growth rate (CAGR), from $259M to $257M.
What does deferred tax assets mean?
Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.